BRF2 and cancer: We sought to determine if the observed alterations in BDP1 in serous ovarian cancer are unique to BDP1 (Figure 1) or are a common feature in all TFIIIB subunits including, BRF1, BRF2, and TBP which have been previously shown to be deregulated in cancer.